Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study.
Kastritis E, Laina A, Georgiopoulos G, Gavriatopoulou M, Papanagnou ED, Eleutherakis-Papaiakovou E, Fotiou D, Kanellias N, Dialoupi I, Makris N, Manios E, Migkou M, Roussou M, Kotsopoulou M, Stellos K, Terpos E, Trougakos IP, Stamatelopoulos K, Dimopoulos MA.
Kastritis E, et al. Among authors: dimopoulos ma.
Leukemia. 2021 May;35(5):1418-1427. doi: 10.1038/s41375-021-01141-4. Epub 2021 Feb 15.
Leukemia. 2021.
PMID: 33589757
Clinical Trial.